TP53 and neoplasm: This might be based on a direct HPyV7-interaction and subsequent deactivation of p53, as recently reported by Rozenblatt-Rosen et al. [40], or alternatively, by clonal integration of the HPyV7 genome with or without tumor-specific viral mutations as has been shown for MCPyV-positive MCCs [11,41].